Temporarily induced facial eczema by IL-17 inhibitors: a case report and literature review
{{output}}
Biologics targeting interleukin-17 (IL-17) are widely used for moderate to severe psoriasis with great efficiency. Nonetheless, their usage has sporadically resulted in paradoxical reactions, such as eczema, sarcoidosis-like eruptions, alopecia areata, and pyo... ...
